NAUT Q4 2021 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

NAUTNautilus Biotechnology, Inc.

$339M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$263,000

Operating Income

-$17M

Net Income

-$17M

EPS (Diluted)

$-0.13

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$12M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$398M

Total Liabilities

$35M

Stockholders' Equity

$364M

Cash & Equivalents

$186M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$263,000	-$194,000	-35.6%
Operating Income	-$17M	-$5M	-216.1%
Net Income	-$17M	-$5M	-211.8%